Early Access — free while we kick the tires
EdgarHawk

Kevin J. Knopp

President and CEO

Director Officer

Latest: President and CEO selling · June 2026

3 filings analyzed · 1 company · Latest 2026-06-25

Companies

Company Buys Sells Direction
908 Devices Inc. MASS 2 3 Net selling

Activity

June 2026
2026-06-25 908 Devices Inc. MASS
low
Sell
60,345 shares
$550,624
Significance 4/10

Kevin Knopp (CEO) sells 60,345 shares at $9.12 avg under 10b5-1 plan; retains 735,623 shares post-transaction.

Kevin J. Knopp, President and CEO of 908 Devices, executed three separate sales totaling 60,345 shares for $550,624.02 at a blended average price of $9.12 across June 23–25, 2026. This represents a -7.6% reduction in his pre-transaction holdings of 795,968 shares. The FLAG indicates this is a scheduled, non-discretionary transaction executed under a 10b5-1 trading plan adopted on 2025-05-20, removing any attribution of timing discretion. The company's fundamentals show net income of $-11,955,000.00 on revenue of $13,381,000.00 (latest quarter) with annual revenue declining -5.8%, alongside a P/E of 16.63 and market cap of $339,566,316.58. The current stock price of $8.98 is -3.8% from the 52-week high of $9.34, though the 30-day and 90-day price changes of +13.4% and +55.4% respectively show recent upward momentum. The sale prices of $9.06–$9.14 are consistent with near-recent-peak valuations, and Knopp retains substantial holdings of 735,623 shares, indicating continued material ownership exposure.

May 2025
2025-05-19 908 Devices Inc. MASS
medium
Buy
15,000 shares
$66,596
Significance 4/10

CEO Knopp buys 15,000 shares of MASS at $4.44; stock up 73.4% in 90 days but 0 of 4 prior buys at this ticker were well-timed.

Kevin J. Knopp, President and CEO, purchased 15,000 shares at $4.44 on 2025-05-15, increasing his holdings to 722,733 shares. At the current price of $4.77, the stock has risen 73.4% over the past 90 days and is trading 30.1% below its 52-week high. However, Knopp's same-ticker purchase history reveals a concerning pattern: of his 5 prior trades at MASS, 4 measured buys show zero instances of well-timed entry—all four prior measurable buys (2024-05-08, 2024-05-09, 2024-05-10, and 2024-05-13) resulted in negative 90-day returns ranging from -19.1% to -32.2%. The company reported a latest-quarter revenue of $11,777,000 and net income of $43,603,000, though it was unprofitable over its most recent full fiscal year. The back-to-back buys (2025-05-14 and 2025-05-15) suggest continued accumulation, but the persistent misalignment with future price movements at this ticker warrants attention to whether this purchase will break that pattern.

2025-05-14 908 Devices Inc. MASS
medium
Buy
15,000 shares
$64,788
Significance 4/10

MASS CEO Knopp buys 15,000 shares at $4.32; stock down 40.3% from 52-week high, CEO prior MASS purchases all negative at 90 days

Kevin J. Knopp, President and CEO of 908 Devices Inc., purchased 15,000 shares at $4.32 on 2025-05-14, bringing his holdings to 707.7K shares. The stock is currently trading at $4.32, down 40.3% from its 52-week high of $7.24 and down 2.3% over the past 30 days, though up 68.8% over 90 days. Notably, Knopp's prior 5 buy transactions at MASS have a poor timing record: 0 of 5 achieved positive 90-day returns, with cumulative 90-day performance ranging from -17.3% to -32.2%. His cross-ticker track record shows a 0.00% 90-day win rate across 5 prior buys. The company's most recent quarter reported revenue of $11.8M with net income of $43.6M, though full-year net income was negative despite 18.7% annual revenue growth. The persistent pattern of unfavorable 90-day outcomes on Knopp's prior MASS purchases and his absence of well-timed buys at this ticker over an extended history warrant investor attention to whether this transaction signals genuine conviction or reflects decision-making that has consistently lagged market movements at this specific security.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access